Bloomberg.com By Michelle Fay Cortez
March 23 (Bloomberg) — The Journal of the American Medical Association is instructing people who unearth possible financial conflicts of interest in studies it has published not to go public with their complaint before editors have completed an investigation of the allegations.
The requirement, part of a new policy at JAMA for dealing with such accusations, was introduced in an editorial published online on March 20, days before the release of the next print edition. The changes follow a correction in an earlier issue that said a researcher studying Forest Laboratories Inc.’s Lexapro for preventing depression in stroke patients failed to disclose previous work for the drug company.
For the rest of the article go to the link at the top of the page.
Last Updated: March 23, 2009 09:22 EDT